Skip to content
RDL Network logo
1694eP Real-world induction targeted therapy (TT) with immune checkpoint inhibitor (ICI) therapy switch in advanced BRAF-mutant melanoma: A multi-institutional study — Jodi A. McKenzie (2025) | RDL Network